ÂÜÀòÂÒÂ×

Daniel Siegel has a solid background in the field of plant biotechnology and Intellectual Property management. With experience working in companies like FuturaGene Ltd., DLS Life Science Management, Meytav Technological Incubator, CollPlant Ltd., and CBD Technologies, Inc., Daniel has held various leadership positions such as VP of Technology & IP Assessment, CEO, and VP Director of IP Development & Strategy. Daniel has a strong educational foundation with a BSc in Agriculture, BioTechnology and an MSc in Biochemistry and Molecular Biology from The Hebrew University of Jerusalem.